TG Therapeutics | TGTX - EPS Earnings Per Share


TG Therapeutics reported $0.05 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.40 2.43 Nov/09
FY2026Q2 Jun/2026 0.05 0.33 0.17 Aug/03
FY2026Q1 Mar/2026 0.12 0.28 0.03 May/06
FY2025Q4 Dec/2025 0.14 0.33 0.15 Feb/26
FY2025Q3 Sep/2025 2.43 0.25 0.02 Nov/03




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Amgen USD 6.29 1.14 Jun/2026
Ardelyx USD -0.15 0.15 Mar/2026
Arrowhead Research USD -1.36 0.43 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Curis USD -11.82 13.04 Mar/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD 0.92 0.95 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
Verastem USD -0.44 0.04 Mar/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026